What's Going On Femasys Shares Today?
Portfolio Pulse from Vandana Singh
Femasys Inc's shares are trading higher after the US Patent and Trademark Office issued a Notice of Allowance for a patent application related to the company's therapeutic product candidate, FemBloc. The patent strengthens Femasys' intellectual property position and coverage for FemBloc, a nonsurgical, non-implant, in-office solution for permanent birth control. The company expects the patent, when issued, to expire in 2039 at the earliest. Femasys' shares are up 108.80% at $0.80.
July 27, 2023 | 4:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Femasys Inc's shares are trading higher after the company received a Notice of Allowance for a patent application related to FemBloc. The patent strengthens Femasys' intellectual property position and is expected to expire in 2039.
The news of the Notice of Allowance for the patent application related to FemBloc strengthens Femasys' intellectual property position. This is likely to boost investor confidence in the company's future prospects, leading to a rise in the company's share price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100